Literature DB >> 8248239

A receptor for interleukin 10 is related to interferon receptors.

A S Ho1, Y Liu, T A Khan, D H Hsu, J F Bazan, K W Moore.   

Abstract

We isolated cDNAs encoding a mouse interleukin 10 receptor (mIL-10R) from mouse mast cell and macrophage cell lines. The two cDNAs are substantially identical and express an approximately 110-kDa polypeptide in COS7 cells, which binds mIL-10 specifically. A mouse pro-B-cell line (Ba/F3) expressing transfected recombinant mIL-10R binds IL-10 with high affinity (approximately 70 pM) and proliferates in response to mIL-10. mIL-10R is structurally related to interferon receptors (IFNRs). Since IL-10 inhibits macrophage activation by IFN-gamma, a possible implication of this relationship interaction of IL-10R and IFN-gamma R or their signaling pathways.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8248239      PMCID： PMC47963          DOI： 10.1073/pnas.90.23.11267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

Review 2.  Cytokine receptors and signal transduction.

Authors:  A Miyajima; T Kitamura; N Harada; T Yokota; K Arai
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity.

Authors:  D H Hsu; K W Moore; H Spits
Journal:  Int Immunol       Date:  1992-05       Impact factor: 4.823

4.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

5.  Behavior of a cloned murine interferon alpha/beta receptor expressed in homospecific or heterospecific background.

Authors:  G Uzé; G Lutfalla; M T Bandu; D Proudhon; K E Mogensen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Receptor antagonist and selective agonist derivatives of mouse interleukin-2.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

9.  The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors.

Authors:  A B Shanafelt; A Miyajima; T Kitamura; R A Kastelein
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307
View more
  49 in total

1.  Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor.

Authors:  Duonan Yu; Diana Cozma; Andrea Park; Andrei Thomas-Tikhonenko
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

2.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

3.  Mapping of the interleukin-10/interleukin-10 receptor combining site.

Authors:  U Reineke; R Sabat; H D Volk; J Schneider-Mergener
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

Authors:  A M O'Farrell; Y Liu; K W Moore; A L Mui
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 5.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

6.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus.

Authors:  S J Busfield; D A Michnick; T W Chickering; T L Revett; J Ma; E A Woolf; C A Comrack; B J Dussault; J Woolf; A D Goodearl; D P Gearing
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

8.  Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.

Authors:  T I Roach; C H Barton; D Chatterjee; F Y Liew; J M Blackwell
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

9.  Functional regions of the mouse interleukin-10 receptor cytoplasmic domain.

Authors:  A S Ho; S H Wei; A L Mui; A Miyajima; K W Moore
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

10.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.